Surgery methods after chemo-radiation for stage 3 rectal cancer
Part of Cancer, Digestive system clinical trials.
This trial compares two different surgery approaches after chemo-radiation for stage 3 rectal cancer. It aims to see which operation helps control the cancer more effectively while keeping surgery as safe as possible.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have rectal adenocarcinoma (a specific colon/rectum cancer type) that is stage 3
- Your tumor can be fully removed with surgery, based on scans and the team’s review
- You have not had chemotherapy or pelvic radiation for any prior cancer
- Your doctor confirms the tumor is low in the rectum (below the peritoneal reflection) and not invading nearby organs in a way that blocks surgery
- No inflammatory bowel disease (like Crohn’s disease or ulcerative colitis)
- You can safely have surgery (and you are not pregnant or breastfeeding)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at a specific type of rectal surgery after you’ve already finished chemo-radiation, aiming to remove the tumor while trying to preserve the anal sphincter (muscle control). It’s meant for people whose cancer can be safely operated on and who don’t have spread to distant organs.
This Phase 3 trial compares two treatment plans given before rectal surgery. It tests whether stronger chemotherapy alone works better than chemotherapy pills plus long-term radiation to improve outcomes for locally advanced rectal cancer.
This trial compares standard chemotherapy to more extensive surgery (total mesorectal excision) for patients whose initial local surgery showed high-risk features like poor differentiation, lymphovascular invasion, or larger tumor size. It aims to find the best treatment to prevent cancer from coming back.
This trial tests how well a precise surgery removes the remaining rectal cancer after you have had radiation and chemotherapy. It is for people whose tumor has shrunk a lot but is still there, and the tumor is very low in the rectum.
This trial compares two different surgery approaches for early-stage rectal cancer (T2N0M0) that is close to the anus. It tests whether a less invasive local removal followed by radiation works as well as more extensive surgery (total mesorectal excision).
This trial compares two approaches for low-risk locally advanced rectal cancer: going straight to surgery (TME) versus receiving chemotherapy before surgery. The goal is to see if upfront surgery works just as well, sparing patients from chemotherapy side effects.
Hear when a new Rectal Neoplasm Malignant trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.